Global Menopausal Disorder Treatment Market Analysis

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Global Menopausal Disorder Treatment Market Analysis

  • Pharmaceutical
  • Apr 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

In recent years, the menopausal disorder treatment market is anticipated to grow rapidly during the forecast period. Menopause is one of the most physically demanding times in a women’s life, prompting worldwide pharmaceutical companies to create effective medications to treat it and related problems. Menopause, also known as the climatic period, occurs when a woman’s menstrual periods stop occurring permanently. Numerous significant changes occur in the female body during this time, resulting in the emergence of several illnesses. Menopausal problems are becoming more common in all parts of the world, and healthcare organizations support the development and use of medications that can effectively treat them. It also has prompted pharmaceutical firms to develop and market medications that alleviate the long term symptoms of menopausal illnesses in women and do not affect their health during or after treatment.

Filled Map Analysis

Frequently Asked Questions

The market is segmented based on Segmentation, By Stages (Menopause, Postmenopause, Perimenopause), Type (Hormonal Therapy and Non-Hormonal Therapy), Menopause Symptoms (Vasomotor Symptoms, Atrophic Vaginitis, Osteoporosis, Joint Pain, Weight Gain, Dyspareunia, Depression, Others), Dosage Form (Tablet, Creams, Gels, Rings/Insert, Patch/Film, Injection Shot, Spray, Others), Route of Administration (Oral, Vaginal, Transdermal, Parenteral), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2032 .
The Global Menopausal Disorder Treatment Market size was valued at USD 14.90 USD Billion in 2024.
The Global Menopausal Disorder Treatment Market is projected to grow at a CAGR of 7.9% during the forecast period of 2025 to 2032.
The major players operating in the market include F. Hoffmann-La Roche Ltd. , Mylan N.V. , Teva Pharmaceutical Industries Ltd., Sanofi , Pfizer Inc. , GlaxoSmithKline plc , Novartis AG , AstraZeneca , Johnson & Johnson Private Limited , Merck & Co.Inc. , Eli Lilly and Company , Abbott , Novo Nordisk A/S , Allergan , Dr. Reddys Laboratories Ltd. , TherapeuticsMDInc. , Ipsen Pharma , Besins Healthcare , Mithra Pharmaceuticals , Ach&eacute, Laborat&oacute,rios Farmac&ecirc,uticos S.A , SEBELA PHARMACEUTICALS , Fervent Pharmaceuticals Inc. , KaNDy Therapeutics , Duchesnay USA .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.